OPPRED: The Strategy of "Pulmonary Opening by Titration of Positive End-expiratory Pressure" Means of a Pulmonary Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome: for Which Patients?

Sponsor
Centre Hospitalier de Lens (Other)
Overall Status
Terminated
CT.gov ID
NCT04028336
Collaborator
(none)
4
4
1
12.6
1
0.1

Study Details

Study Description

Brief Summary

Pulmonary recruitment maneuvers open these lung areas and appropriate adjustment of positive expiratory pressure (PEP) helps to stabilize recruitment and reduce the stress associated with alveolar opening and closing. Its beneficial effects in the lung affected by Acute Respiratory Distress Syndrome (ARDS) remain unclear. The hypothesis is that there is a heterogeneous effect of the recruitment maneuver according to the phenotype of ARDS. It is important to be able to define responder patients from non-responders to this recruiting maneuver.

Condition or Disease Intervention/Treatment Phase
  • Other: TITRATION
N/A

Detailed Description

It will be a prospective interventional study in resuscitation patients with severe or moderate ARDS. This study will be multicentric between the University Hospital of Amiens and intensive care of Lens, intensive care of Bethune and intensive care of Arras. All patients in intensive care and severe, moderate ARDS will be included in this study. All patients will benefit from Lung ultrasound (LUS) with a mapping of each lung looking for normal or pathological lung profiles, as well as a measurement of esophageal pressure (Peso) at rest. A "PEP titration pulmonary opening" (PEP-OP) test using a recruitment maneuver was then performed in all patients followed by a new LUS and Peso measurement.

Study Design

Study Type:
Interventional
Actual Enrollment :
4 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
All patients in intensive care and severe, moderate ARDS will be included in this study. All patients will benefit from Lung ultrasound (LUS) with a mapping of each lung looking for normal or pathological lung profiles, as well as a measurement of esophageal pressure (Peso) at rest. A "PEP titration pulmonary opening" (PEP-OP) test using a recruitment maneuver was then performed in all patients followed by a new LUS and Peso measurement.All patients in intensive care and severe, moderate ARDS will be included in this study. All patients will benefit from Lung ultrasound (LUS) with a mapping of each lung looking for normal or pathological lung profiles, as well as a measurement of esophageal pressure (Peso) at rest. A "PEP titration pulmonary opening" (PEP-OP) test using a recruitment maneuver was then performed in all patients followed by a new LUS and Peso measurement.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Strategy of "Pulmonary Opening by Titration of Positive End-expiratory Pressure" Means of a Pulmonary Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome: for Which Patients?
Actual Study Start Date :
Dec 20, 2019
Actual Primary Completion Date :
Jan 7, 2021
Actual Study Completion Date :
Jan 7, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: TITRATION

All patients hospitalized in intensive care and meeting inclusion criteria and without criteria for non-inclusion will be included in this study. All patients will benefit from Lung ultrasound (LUS) and esophageal pressure measurement (Peso) according to the habits of the service. A "PEP titration pulmonary opening" (PEP-OP) test using a recruitment maneuver was then performed in all patients followed by a new LUS and Peso measurement.

Other: TITRATION
PEP titration pulmonary opening (PEP-OP) was performed in all patients followed by new LUS and Peso measurement.

Outcome Measures

Primary Outcome Measures

  1. oxygenation and pulmonary compliance [at 1 hours of the PEP-OP test.]

    The primary outcome is oxygenation (PaO2 / FiO2) and pulmonary compliance ((Pplat-Pep) / VT) at 1h of the PEP-OP test.

Secondary Outcome Measures

  1. Oxygenation (PaO2 / FiO2) at 6h, 12h, 24h [at 6 hours, 12 hours, 24 hours of the PEP-OP test]

    Oxygenation (PaO2 / FiO2) at 6h, 12h, 24h

  2. Mechanical ventilation time [Discharge from intensive care unit]

    Mechanical ventilation time

  3. Hospitalization in intensive care time [Discharge from intensive care unit]

    Hospitalization in intensive care time

  4. The need for recourse to alternative therapies of oxygenation [Discharge from intensive care unit]

    The need for recourse to alternative therapies of oxygenation

  5. Incidence of barotrauma [After PEP-OP]

    Incidence of barotrauma

  6. Pulmonary compliance at 6 hours, 12 hours and 24 hours [at 6 hours, 12 hours and 24 hours of the PEP-OP test.]

    Pulmonary compliance at 6 hours, 12 hours and 24 hours

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Will be included in the study, patients:
  • Major patient (age ≥18 years)

  • Controlled assisted ventilation, sedation and curarization adapted to the respirator.

  • Within the first 72 hours of an ARDS (PaO2 / FiO2 ≤ 200 mmHg, FiO2 ≥ 60% and PEEP of ≥5 cmH20) (as recommended by the Berlin criteria)

  • Decision of intensivist in charge of the patient to put an oesophageal probe

  • After hemodynamic optimization (evaluation of the preload dependence and need for catecholamines)

  • Decision of the intensivist in charge of the patient to perform a pulmonary opening test by titration of PEEP by means of a pulmonary recruitment test.

Exclusion Criteria:
  • Patients under the age of 18

  • Pregnant women, women who are parturient or breastfeeding

  • Patients with pulmonary broncho-emphysematous pathology or at risk of presenting it.

  • Patients with a history of barotrauma or at risk of presenting it.

  • Patients with a history of intracranial hypertension

  • Patients with suspected or proven right ventricular dysfunction or uncontrolled hemodynamic instability after hemodynamic management.

  • Patients with a contraindication to the placement of an oesophageal tube (esophageal surgery, severe esophageal pathology)

  • Patients under guardianship or curatorship or deprived of liberty.

  • Patients who are legally protected

  • Patient not covered by French national health insurance

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu Amiens Amiens France 80054
2 CH Arras Arras France 62000
3 Ch Germon Et Gauthier Béthune France 62408
4 Hospital Dr Schaffner Lens France 62307

Sponsors and Collaborators

  • Centre Hospitalier de Lens

Investigators

  • Principal Investigator: Julien MARC, DR, Hospital of Lens

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier de Lens
ClinicalTrials.gov Identifier:
NCT04028336
Other Study ID Numbers:
  • PI2019-01/OPPRED/DRMARC
First Posted:
Jul 22, 2019
Last Update Posted:
Mar 4, 2021
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 4, 2021